NCT05687864View on ClinicalTrials.gov

Study of Polyglycan Superparamagnetic Ferric Oxide Injection on Cardiovascular Magnetic Resonance Imaging

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 17, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Magnetic Resonance ImagingChronic Kidney Diseases
Interventions
DIAGNOSTIC_TEST

Polysaccharide superparamagnetic ferric oxide injection

The polysaccharide superparamagnetic ferric oxide injection is a clinical diagnostic reagent

Trial Locations (1)

100020

RECRUITING

Beijing Chaoyang Hospital, Capital Medical University, Beijing

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY